{"schema_version":"secwatch.filing_event.v1","accession":"0001816590-22-000073","form_type":"8-K","ticker":"CMPS","cik":"0001816590","company_name":"COMPASS Pathways plc","filed_at":"2022-07-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.175661+00:00","generated_at":"2026-06-24T12:29:57.157392+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"COMPASS Pathways appoints Kabir Nath as CEO effective August 1, 2022; George Goldsmith becomes Executive Chairman","bullets":["Kabir Nath appointed CEO, effective August 1, 2022; he brings 30 years biopharma experience, most recently at Otsuka and Bristol-Myers Squibb.","George Goldsmith transitions to Executive Chairman from Aug 1 to Dec 31, 2022, then remains Chairman; his base salary is £346,800 with 55% target bonus.","Nath receives $580,000 base salary, 60% target bonus, 600,000 stock options and 50,000 RSUs vesting over four years.","Nath also gets a £12,000/month housing stipend through Aug 2023, $5,000 legal fees, and $250,000 relocation payment.","Goldsmith's pro-rated 2022 bonus reflects reduced salary from August; employment ends Dec 31, 2022 per amended agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001816590-22-000073","json":"https://secwatch.observer/filing/0001816590-22-000073.json","markdown":"https://secwatch.observer/filing/0001816590-22-000073.md","text":"https://secwatch.observer/filing/0001816590-22-000073.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1816590/000181659022000073/0001816590-22-000073-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1816590/000181659022000073/cmps-20220719.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T12:29:57.157392+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"12952b0f19","claim":"Kabir Nath was appointed as chief executive officer at COMPASS Pathways plc.","evidence_excerpt":"On July 19, 2022, COMPASS Pathways plc (the “Company”) announced that its board of directors has appointed Kabir Nath as the Company’s chief executive officer effective August 1, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1816590/000181659022000073/0001816590-22-000073-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"chief executive officer"}],"fact_type":"executive_change"},{"claim_id":"c23d52e42e","claim":"Kabir Nath was appointed as Class II director at COMPASS Pathways plc.","evidence_excerpt":"Mr. Nath will also be appointed as a member of the board of directors as a Class II director effective as of August 1, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1816590/000181659022000073/0001816590-22-000073-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class II director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}